Weight management is a significant challenge for many, particularly for those with obesity or related health conditions. Diet and exercise alone may not lead to the desired outcomes for everyone. Moreover, biological factors such as insulin resistance and hormonal imbalances often make sustainable weight loss more complex than it seems.
According to the CDC, nearly 74% of adults in the US are classified as overweight. Obesity-related conditions contribute to some of the leading causes of preventable death. Despite the growing availability of weight management resources, many individuals still find themselves searching for solutions.
Victoza, an injectable drug formulated for type 2 diabetes management, has gained attention for its role in weight loss. This article explains how Victoza for weight loss works, explores its benefits and risks, and offers practical tips for those considering it.
Is Victoza approved for weight loss?
No. While Victoza may lead to some weight loss, its approved indication is to manage blood sugar levels in type 2 diabetes patients aged 10 years and older. It’s also indicated to reduce the risk of major cardiovascular events (MACE) in adults with type 2 diabetes and established heart disease.
Good to Know:
Saxenda and Victoza both contain liraglutide. Saxenda is specifically formulated and approved for weight management. It is administered at a higher dose (up to 3 mg daily) compared to Victoza (up to 1.8 mg daily), targeting appetite control and supporting sustained weight loss when combined with diet and exercise.
How does Victoza work for weight loss?
Here’s how Victoza contributes to weight loss:
-
- Slows Gastric Emptying: Victoza delays the movement of food and creates a sensation of fullness for longer periods, which helps reduce overall calorie intake.
-
- Suppresses Appetite: Victoza influences the hypothalamus, located at the base of the brain, to decrease cravings. This helps individuals to adhere to a lower-calorie diet.
-
- Improves Insulin Sensitivity: This helps regulate blood sugar levels and may reduce fat storage, particularly around the abdomen.
-
- Reduces Post-Meal Glucose Spikes: Victoza decreases glucagon secretion to prevent large spikes in blood sugar after meals. Stabilized blood sugar levels can help reduce energy crashes and subsequent overeating.
Note that Victoza is not a standalone solution. It should be combined with lifestyle changes like improved diet and increased physical activity.
Warning!
Victoza is NOT available in a 3 mg dose. The maximum approved dose for Victoza is 1.8 mg daily. Be cautious when purchasing medications, as counterfeit products claiming to be “Victoza 3 mg” for weight loss may circulate.
What is the recommended Victoza dose for weight loss?
Victoza does not have a specific dosage regimen exclusively approved for weight loss. If you start using Victoza, the typical initial dose is 0.6 mg once daily. This dose is primarily meant to minimize gastrointestinal side effects and is not effective for controlling blood sugar or supporting weight loss.
After one week, your dose is usually increased to 1.2 mg once daily. It may be further increased to a maximum of 1.8 mg once daily if you need additional support. Consult your healthcare provider for the appropriate Victoza dosing for weight loss.
How to use Victoza for weight loss?
Here’s a general overview, but it’s important to rely on your doctor’s instructions:
-
- Consult your doctor: Victoza should only be used under the supervision of a professional. Share your weight loss goals, medical history, and any other medications you are taking to ensure its safety.
-
- Inject at the same time each day: Use Victoza as a subcutaneous injection in the abdomen, thigh, or upper arm. Rotate the injection site to avoid irritation. Take it at a consistent time each day, with or without food.
-
- Adopt healthy lifestyle changes: Victoza works best when combined with a calorie-controlled diet and regular exercise. It is not a standalone solution for weight loss but a tool to assist in your overall plan.
-
- Monitor for side effects: Report any unusual symptoms to your doctor.
-
- Track your progress: Monitor your weight regularly and discuss your progress with your doctor. If you do not see significant weight loss after a few months, your doctor may recommend adjusting the dose or considering alternative treatments.
-
- Do not exceed the prescribed dosage: Taking more than the prescribed dose will not accelerate weight loss and could increase the risk of side effects.
More importantly, do not make any changes to your medication regimen without consulting your doctor.
Takeaway
Victoza is not FDA-approved for weight loss but may be prescribed off-label for this purpose. It aids weight loss by suppressing appetite, slowing gastric emptying, and improving insulin sensitivity. Studies demonstrate modest weight loss outcomes, though results can vary.
If you are considering Victoza for weight management, consult a healthcare provider who can tailor the treatment to your needs. Always prioritize safety by adhering to your doctor’s recommendations, avoiding unapproved dosages, and considering a second opinion if needed. Victoza can be a helpful tool, but it should be part of a comprehensive plan that includes diet, exercise, and medical supervision.
Frequently Asked Questions
Related Articles
Sources
García-Cantú, E. A., Alvarado-Saldaña, H. H., Támez-Pérez, H. E., & Rubio-Aguilar, G. (2014, April 1). Effects of liraglutide on weight reduction and metabolic parameters in obese patients with and without type 2 diabetes mellitus. Medicina Universitaria. https://www.elsevier.es/en-revista-medicina-universitaria-304-articulo-effects-liraglutide-on-weight-reduction-X1665579614365466?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1
NovoMedlink. (n.d.). How to dose and administer Victoza. Retrieved from https://www.novomedlink.com/diabetes/products/treatments/victoza/dosing-administration.html
Victoza Official Website. (n.d.). https://www.victoza.com/
Novo Nordisk. (2024). Highlights Of Prescribing Information of Victoza. Retrieved from https://www.novo-pi.com/victoza.pdf
Kim, S. H., Abbasi, F., Lamendola, C., Liu, A., Ariel, D., Schaaf, P., Grove, K., Tomasso, V., Ochoa, H., Liu, Y. V., Chen, Y. I., & Reaven, G. (2013). Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Diabetes Care, 36(10), 3276–3282. https://doi.org/10.2337/dc13-0354
Dungan, K. M., Povedano, S. T., Forst, T., González, J. G. G., Atisso, C., Sealls, W., & Fahrbach, J. L. (2014). Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial. The Lancet, 384(9951), 1349–1357. https://doi.org/10.1016/s0140-6736(14)60976-4
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). The Lancet, 374(9683), 39–47. https://doi.org/10.1016/s0140-6736(09)60659-0
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/nejmoa2206038





